Enterprise Healthcare Account Executive

Brellium raises $23M to expand AI clinical compliance platform. 14 October 2026 Key Takeaways * Brellium raised $23 million in funding led by Left Lane Capital and First Round Capital. * Its CortexLM system audits clinical documentation to identify compliance risks and unbilled revenue. * The company plans to expand into cardiology, pain management and primary care. Brellium raises $23M to strengthen healthcare compliance. Brellium has raised $23 million to expand its AI-powered clinical compliance and revenue integrity platform. Left Lane Capital and First Round Capital led the funding round. Digital Health Venture Partners also participated. Its customer base includes over 200 provider groups across multiple healthcare specialties. The New York-based company helps healthcare providers identify documentation errors before billing. Its platform aims to reduce compliance risks and prevent costly insurance recoupments. Brellium serves more than 215,000 providers across all 50 US states. Brellium says it's audited 22 million patient visits so far. On top of that, the company claims it's protected nearly $2 billion in provider revenue from being clawed back. Providers are under a lot more scrutiny now, both from public and private payers. They need to prove their clinical records actually back up their billing claims and follow all the rules. If notes are incomplete or if billing codes aren't supported, things can get messy. Problems found after billing lead to denied claims, repayments, even more investigations. The goal is pretty clear: catch issues earlier by automating chart audits, so providers can fix problems before sending in claims. Brellium's also planning to work with more provider groups and move into additional clinical specialties. CortexLM helps providers identify billing risks. Brellium's CortexLM uses AI to identify clinical documentation gaps, coding errors and billing risks, helping healthcare providers strengthen compliance and protect revenue from potential recoupments. Source: Created by Ventureburn. Brellium has also introduced CortexLM, its proprietary clinical chart-auditing system. The platform analyses patient notes to identify documentation gaps, coding errors and potential compliance issues. CortexLM checks records against each provider's specific requirements. It then flags problems and proposes corrections before claims reach payers. The process aims to reduce denied claims and prevent repayment demands. Better documentation may support more accurate claims, although providers remain responsible for reviewing findings and meeting payer requirements. Brellium says CortexLM has helped protect nearly $2 billion in provider revenue from recoupments. Its technology also supports quality assurance by reviewing clinical documentation more comprehensively. Headspace expanded its clinical quality programme after adopting Brellium. Brellium targets new medical specialties. Brellium's new funding gives the company a shot at growing beyond its current customers. They're getting ready to jump into new areas: cardiology, pain management, and primary care. These fields aren't simple; they come with piles of paperwork and tricky billing rules that change depending on the specialty. More providers will get access to automated reviews, which really can save time and cut down on mistakes. On top of that, Brellium wants to dig deeper into the revenue cycle. They're looking to help healthcare providers spot where they're losing money or risking compliance issues as they bill. Their CEO doesn't mince words; he says the Brellium platform is now essential for healthcare providers. The thing is, these tools only matter if teams know how to use them. Staff need to understand why a note was flagged and what steps to take next. Clear review guidelines make a difference, helping folks see the line between missing info and acceptable differences in clinical judgement. But there's more. Providers have to keep patient data safe and make sure the automated advice fits their practice policies. That means everyone across departments and specialties has to follow consistent, reliable workflows. Brellium has what it needs to keep building CortexLM and reach more customers. The next chapter is all about growing the user base and helping providers nail compliance while protecting revenue. To stay updated on crypto venture capital funding and market trends, visit its venture capital news section for more insights. Clinton Nwachukwu is a crypto and finance writer with an MBA in Artificial Intelligence and 6+ years of experience creating content for leading global brands. He turns complex topics into clear, actionable insights for readers worldwide. Disclaimer VentureBurn is a media platform covering the latest in cryptocurrency, artificial intelligence, venture capital, and the startup ecosystem. Opinions expressed on VentureBurn are for informational purposes only and do not constitute investment advice. Before making any high-risk investments in digital assets or emerging technologies, readers should conduct their own due diligence. All transactions and financial decisions are made at your own risk, and any losses incurred are solely your responsibility. VentureBurn does not endorse or recommend the buying or selling of any digital assets and is not a licensed investment advisor. Please note that VentureBurn may participate in affiliate marketing programs.

Brellium raises $23M for CortexLM and specialty expansion. Headspace's clinical quality program went from reviewing 2% of therapy notes to reviewing all of them after adopting Brellium, according to the software company's latest announcement. That change puts a familiar management problem on a much larger surface: somebody must turn the findings into useful instructions for the people providing care. Brellium announced $23M in venture funding on October 13, 2026, led by Left Lane Capital and First Round Capital, with Digital Health Venture Partners participating. The New York healthcare technology company also introduced CortexLM, a system intended to identify documentation and compliance problems before billing. The financing will support additional clinical specialties and deeper work in the revenue cycle, extending a business built around getting the record ready before the payment is contested. What Brellium's $23M venture funding supports. Brellium plans to expand into cardiology, pain management and primary care while serving more provider groups. The company describes CortexLM as reviewing clinical notes against the requirements that apply to a provider and proposing corrections before claims go out. Its ambition reaches the interval between the patient visit and the bill, when a team still has an opportunity to repair documentation without reconstructing an entire episode later. Left Lane Capital and First Round Capital are returning backers. Brellium's first-party historical coverage identifies a separate $16.7M Series A in 2025; the current release names Digital Health Venture Partners as a participant in the new financing. The announcement calls the new capital venture funding and leaves the named series, valuation and cumulative funding total undisclosed. The timing of review is a commercial decision as well as a software feature. A flag arriving before billing can give a provider a practical task: clarify the record, check the code or resolve the documentation gap. For a buyer, the useful question becomes how that task fits into a clinic's existing work. An alert that reaches the right person in time has a different operating value from a finding that arrives after staff have moved on to another day's patients. Clinical documentation becomes a management relationship. Brellium's current leadership page identifies four co-founders: CEO Zach Rosen, COO Henry Kasa, Alex Le-Tu, and Head of Engineering Max Katzman. Founded in 2021, the company develops software around chart review, compliance and coding. That puts its founders in a demanding relationship with customers whose documentation has to serve clinicians, billing teams and payer requirements at once. In a July 2026 interview summarized by Euclid Ventures, Rosen described compliance feedback as a form of workforce training. He explained that a provider can learn from review findings and carry that understanding into later documentation. The observation gives the product a purpose beyond catching a single mistake: help the team become more capable of writing the next record. That learning depends on choices inside the provider organization. Who receives the finding? Who understands why it matters? Who can decide whether the suggested change reflects the visit accurately? Software can make a requirement visible, while the clinical organization still has to assign responsibility for the response. The combination is what makes wider review consequential: findings can become shared practice, rather than remain inside the memory of the person who happened to conduct an audit. Payer knowledge is part of the product. Rosen's July account included a customer that encountered a payer requirement through an enforcement action before the requirement appeared in a public bulletin. Brellium used that experience to explain the value of learning how standards are applied, alongside reading what the published standards say. The episode is a company executive's account, but the operating question it raises is concrete: how quickly can useful knowledge reach another provider facing the same requirement? For healthcare software buyers, that question connects product accuracy with information maintenance. A review system has to translate a requirement into something a team can act on, then keep that interpretation useful as practices and expectations change. A static checklist and a feedback process impose different responsibilities on the vendor. Brellium's strategy places that continuing work close to its relationship with providers. Competition for the clinic's attention also comes from the workflows already surrounding the record. Brellium's website says its software integrates with existing electronic health record systems. The commercial proposition therefore includes fitting review into the tools and routines a clinic already uses. Buying another application is easier to justify when the findings have somewhere to go, a responsible person to receive them and a clear route back into the documentation. Specialty expansion multiplies the translation work. Moving from established use cases into cardiology, pain management and primary care gives Brellium more settings in which to apply its approach. It also gives the team more variation to understand. The value of pre-billing review depends on whether a requirement becomes a useful correction in the context of the care actually delivered; a larger specialty footprint makes that relationship more varied. The new announcement includes a company promise to cover repayment costs when a payer finds a problem in a record Brellium previously cleared. Its public release does not spell out the contractual conditions. That promise deserves attention because it brings financial responsibility into the vendor's product claim, while leaving the buyer with a practical diligence question about the coverage that applies to its own agreement. A cardiology group assessing CortexLM will need explanations its clinicians can use, while a pain-management group will bring its own documentation questions. Brellium's founders now have more capital to carry those conversations into specialties where the next useful review begins with understanding what the provider needs to record. DevCuration Data Healthcare AI funding, last 30 days. DevCuration's funding database tracked 15 Healthcare AI rounds totaling $686.8M in disclosed capital over the past 30 days. Recent deals DevCuration covered: